fatigue
[대역어] 피로
[용어속성] Symptom
[용어속성] Symptom
Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients
Article
[키워드] 95% CI
Asymptomatic
BMI
Care
cohort study
Comorbidities
Concentration
conducted
COVID-19
COVID-19-related symptoms
demographics
disease
Epidemiology
Factor
fatigue
female
Follow-up
headache
Health
Health policy
heterogeneity
Hospitalization
Infectious diseases
memory
men
MOST
Odds ratio
Outcomes research
participant
Participants
Patient
PCR
PCR-confirmed COVID-19 patient
persistent
polymerase chain
Prevalence
public health
questionnaire
raised
reduced
Registration
report
reported
risk factor
Risk factors
sensitivity analysis
Sex
Signs and symptoms
Symptom
symptomatic participant
Symptoms
syndrome
System
viral infection
with COVID-19
women
[DOI] 10.1038/s41598-021-92045-x PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-92045-x PMC 바로가기 [Article Type] Article
Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning
Artificial Intelligence
[키워드] age
artificial intelligence
calculation
chest pain
clinician
Clinicians
cough
COVID-19
COVID-19 patient
COVID-19 vaccine
COVID-19-related symptom
death
disorder
disorders
distress
distribution
fatigue
Fever
gastrointestinal symptoms
Gender
group
groups
headache
healthcare
Hospitalization
IMPROVE
individuals
information
Loss of Smell
machine learning
ML model
Mortality
mortality risk
muscular pain
occurred
outcomes
paralysis
Patient
predict
prediction
Prevalence
reduce
resources
risk
Self-isolation
sensitivity
severity
sore throat
specificity
study population
Symptom
Symptoms
the disease
Vaccine
vertigo
[DOI] 10.3389/frai.2021.673527 PMC 바로가기 [Article Type] Artificial Intelligence
[DOI] 10.3389/frai.2021.673527 PMC 바로가기 [Article Type] Artificial Intelligence
Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
Review
Published on
Journal: Quality of life research : an international journa [Category] COVID-19, MERS, SARS,
Journal: Quality of life research : an international journa [Category] COVID-19, MERS, SARS,
[키워드] Abstract
Active disease
Clinicians
Cognitive function
Concerns
consequence
Course
COVID-19
criteria
data extraction
discrepancies
fatigue
Fever
Follow-up
for inclusion
health-related quality of life
identify
information
International
knowledge
literature review
myalgia
neurological
Patient
Patient-reported outcome
patients with COVID-19
problem
provide
provided
Psychological
Quality of life
questionnaire
recognize
resolved
Result
selected
supplementary material
Symptom
Symptoms
systematic literature search
systematic review
the disease
Treatment
was performed
with COVID-19
[DOI] 10.1007/s11136-021-02908-z PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s11136-021-02908-z PMC 바로가기 [Article Type] Review
Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
Article
[키워드] affected
age
AstraZeneca
AZD1222
benefit
Blood
carried
ChAdOx1 nCoV-19
chill
chronic
Chronic illness
composed
COVID-19
COVID-19 vaccine
cross-sectional
Czech Republic
Demographic variables
disorder
drug-related side effects and adverse reactions
EMA
European Medicines Agency
evaluate
Evidence
fatigue
female
Frequency
Gender
Germany
headache
Health personnel
healthcare worker
illness
incidence
increased risk
independent
Infection
injection site pain
Local
majority
mass vaccination
medical treatment
medical treatments
nausea
Oxford–AstraZeneca vaccine
Pain
participant
Participants
potential risk
Prevalence
questionnaire
receiving
recent
reported
required
resolved
Safety
Side effect
state
supported
the vaccine
thrombosis
urgent investigation
Vaccine
[DOI] 10.3390/vaccines9060673 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines9060673 PMC 바로가기 [Article Type] Article
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
Article
[키워드] clinical trials
collected
conducted
COVID-19
COVID-19 pandemic
COVID-19 vaccine
demographic data
dose
Effect
Effectiveness
evaluate
evaluated
fatigue
female
Final
Infection
injection
introduced
median age
Mild
moderate
MOST
not different
Oxford-AstraZeneca
Pain
participant
Pfizer-BioNTech
profile
questionnaire
receiving
recipient
reported
Retrospective study
Safe
SARS-CoV-2
Saudi Arabia
side
Side effect
Side effects
study participant
Study participants
subject
subjects
Vaccine
vaccine-associated side effect
Vaccines
with COVID-19
[DOI] 10.3390/vaccines9060674 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines9060674 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
HIV 감염에서 SARS-COV-2에 대한 Chadox1 NCOV-19 (AZD1222) 백신의 안전성 및 면역 원성 : 2/3 상 임상 시험의 단일 암 보체.
Clinical Trial
[키워드] ACHE
age
All participants
analysed
analyses
anti-Spike IgG
anti-spike IgG response
Anti-spike IgG responses
antibody
Antiretroviral therapy
ART
AstraZeneca
available data
AZD1222
CD4
CD4 cell
CD4 count
CD4 counts
Cell
cell-mediated immune response
Cell-mediated immune responses
cellular response
Cellular responses
ChAdOx1
ChAdOx1 nCoV-19
chill
chills
Clinical research
clinical trial
Coalition
Comorbidity
determined by
dose
Eligible participants
ELISA
ELISPOT
enrolled
enrolment
enzyme
enzyme-linked immunospot assay
fatigue
finding
FIVE
frequencies
Frequency
functional
funding
General population
headache
HIV
HIV clinics
HIV-negative
HIV-uninfected
humoral
Humoral response
humoral responses
IFN-γ
IgG response
IgG responses
immune responses
Immunity
immunogenic
immunogenicity
injection
injection site
Innovation
IQR
joint
joint pain
less
Live virus
Local
London
magnitude
malaise
male
median
median age
muscle ache
nausea
network
neutralisation
NIHR
NIHR Oxford Biomedical Research Centre
no correlation
no difference
occurred
Open-label
outcome
Oxford
Pain
participant
Participants
peaked
people with HIV
persistence
phase 2/3
phase 2/3 trial
plasma
Primary outcome
Primary outcomes
prime-boost regimen
proliferation
proliferative
protocol
reactogenicity
Registered
reported
required
response
Safe
Safety
SARS-CoV-2
SARS-CoV-2 spike-specific
Serious Adverse Event
Serious Adverse Events
single-arm
South
sustained
systemic reaction
systemic reactions
T-cell
the vaccine
undetectable
vaccination
Vaccine
vaccine immunogenicity
Valley
Viral
Viral load
were measured
with HIV
[DOI] 10.1016/S2352-3018(21)00103-X PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1016/S2352-3018(21)00103-X PMC 바로가기 [Article Type] Clinical Trial
The Feasibility and Effects of a Telehealth-Delivered Home-Based Prehabilitation Program for Cancer Patients during the Pandemic
Observational Study
[키워드] cancer care
cancer treatment
Complete
coronavirus
deconditioning
Effect
enrolled
exercise oncology
fatigue
feasibility
feasible
Health
Intervention
measure
outcome
pandemic
Patient
patients
post-intervention
prehabilitation
Primary outcome
Program
PROTECT
psychological support
questionnaire
Questionnaires
recruited
scale
secondary outcome
shielding
significantly
study period
Surgical oncology
Therapies
[DOI] 10.3390/curroncol28030207 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.3390/curroncol28030207 PMC 바로가기 [Article Type] Observational Study
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Article
[키워드] Antigen
association
Asymptomatic COVID-19
Brain
chronic COVID syndrome
control subject
coronavirus
Coronavirus disease 2019
COVID
COVID-19
COVID-19 patient
determine
disease
EBV
Epstein-Barr virus
Epstein–Barr virus
Epstein–Barr virus
Epstein–Barr virus reactivation
fatigue
Fisher’s exact test
IgG
IgM
Infection
investigation
Long
Long COVID
occur
Occurrence
PACS
Patient
positive
Post-acute COVID-19 syndrome
Prevalence
Randomly
rashes
Reactivation
recruited
relationship
SARS-CoV-2
study group
subject
Symptom
Symptoms
the SARS-CoV-2 virus
with COVID-19
[DOI] 10.3390/pathogens10060763 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/pathogens10060763 PMC 바로가기 [Article Type] Article
Immune Response, Viral Shedding Time, and Clinical Characterization in COVID-19 Patients With Gastrointestinal Symptoms
Medicine
[키워드] Admission
analyzed
bilateral pneumonia
C-reactive protein
Characteristics
characterization
clinical
Clinical characteristics
clinical characterization
Clinical outcome
coronavirus disease
COVID-19
COVID-19 case
COVID-19 patient
Critical disease
CRP
determine
develop
Epidemiology
fatigue
Gastrointestinal
gastrointestinal symptoms
GI symptom
GI symptoms
groups
IgM
IL-6
immune response
Immunoglobulin
increase
interleukin-6
Kidney injury
laboratory abnormalities
LDH
Liver injury
lymphocyte
lymphopenia
Neutrophil-to-lymphocyte ratio
NLR
not differ
Patient
PCT
previous study
procalcitonin
reported
response
Retrospective study
SAA
selected
serum
severe disease
Severity of infection
shedding
significant changes in
significantly higher
survival rate
susceptibility
Symptom
Symptoms
time
Treatment
two group
two groups
viral shedding
was performed
with COVID-19
[DOI] 10.3389/fmed.2021.593623 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.593623 PMC 바로가기 [Article Type] Medicine